Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 22, 2023
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
Journal: Cancer cell
Published: February 06, 2023
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: January 04, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Journal: Cancer discovery
Published: September 12, 2022
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.
Journal: European urology
Published: July 30, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectives.
Journal: Urologic oncology
Published: January 19, 2021
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy.
Journal: The Prostate
Published: September 09, 2019
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 29, 2018
Last Updated: 09/26/2026